Abstract Parkinson's disease is the most common neurodegenerative movement disorder. α-Synuclein is a small synaptic protein that has been linked to familial Parkinson's disease (PD) and is also the primary component of Lewy bodies, the hallmark neuropathology found in the brain of sporadic and familial PD patients. The function of α-synuclein is currently unknown, although it has been implicated in the regulation of synaptic vesicle localization or fusion. Recently, overexpression of α-synuclein was shown to cause cytoplasmic vesicle accumulation in a yeast model of α-synuclein toxicity, but the exact role α-synuclein played in mediating this vesicle aggregation is unclear. Here, we show that α-synuclein induces aggregation of many yeast Rab GTPase proteins, that α-synuclein aggregation is enhanced in yeast mutants that produce high levels of acidic phospholipids, and that α-synuclein colocalizes with yeast membranes that are enriched for phosphatidic acid. Significantly, we demonstrate that α-synuclein expression induces vulnerability to perturbations of Ypt6 and other proteins involved in retrograde endosome-Golgi transport, linking a specific trafficking defect to α-synuclein phospholipid binding. These data suggest new pathogenic mechanisms for α-synuclein neurotoxicity.
Introduction
Parkinson's disease (PD) is characterized clinically by bradykinesia, resting tremor, stooped posture, and rigidity (Galvin et al. 2001) . Lewy bodies (LBs), the hallmark lesions found in the brain of patients with PD, are composed of α-synuclein amyloid fibrils (Spillantini et al. 1997) , and α-synuclein can form similar fibrils in vitro in a time and concentration-dependent manner (Conway et al. 1998; Giasson et al. 1999; Wood et al. 1999) . The identification of point mutations, i.e. A53T, A30P, and E46K, as well as duplications and triplications in the α-synuclein gene in early onset familial PD (Polymeropoulos et al. 1997; Kruger et al. 1998; Singleton et al. 2003; Chartier-Harlin et al. 2004; Zarranz et al. 2004 ) support a pivotal role for α-synuclein in the etiology and pathogenesis of PD. For example, mutations associated with early onset familial PD accelerate in vitro fibril formation (Conway et al. 1998; Li et al. 2002; Greenbaum et al. 2005) , and transgenic mice overexpressing mutant A53T α-synuclein developed motoric phenotypes and LB-like inclusions (Giasson et al. 2002; Lee et al. 2002) . These observations suggest that α-synuclein is directly involved with the pathogenesis of PD and strongly implicates fibril formation as a pathogenic mechanism.
α-Synuclein is a 140 amino acid protein of unknown function that localizes to synaptic vesicles in rat brain (Jakes et al. 1994; Iwai et al. 1995) . The N terminus of α-synuclein contains six imperfect repeats of the KTKEGV motif which resembles the lipid binding domain of apolipoproteins (Segrest et al. 1992 ) and adopts an α-helical structure that facilitates membrane binding when in the presence of acidic phospholipids (Jensen et al. 1998; Perrin et al. 2000; Jao et al. 2004; Kubo et al. 2005 ; Kim et al. 2006; Stockl et al. 2008) . Although α-synuclein knockout mice are viable with no abnormal brain morphology, these animals exhibit reduced levels of striatal dopamine and an attenuated response to amphetamine (Abeliovich et al. 2000; Yavich et al. 2004) . Moreover, cultured hippocampal neurons from α-synuclein knockout mice have a decreased reserve pool of synaptic vesicles, as well as a decrease in the number of docked vesicles (Cabin et al. 2002) . These data suggest that α-synuclein regulates synaptic vesicle trafficking at the synapse. Consistent with these observations, α-synuclein overexpression in PC12 cells results in an increase in docked vesicles at the synapse, further supporting the role of α-synuclein in vesicle tethering to the presynaptic plasma membrane (Larsen et al. 2006) . In this regard, α-synuclein compensates for the loss of cysteine string protein-α (CSPα), a synaptic chaperone, and rescues deficits in SNARE complex assembly in CSPα knockout mice (Chandra et al. 2005 ) and antagonizes SNARE function in mammalian cells (Thayanidhi et al. 2010) . The relationship between the ability of α-synuclein to regulate the synaptic vesicle cycle and the progression of human disease is currently unknown.
We previously reported a vesicle accumulation phenotype in Saccharomyces cerevisiae overexpressing human α-synuclein (Soper et al. 2008 ). This morphological phenotype is accompanied by cellular toxicity and disruption of Golgi organization and requires the integrity of both the α-synuclein N-terminal and central hydrophobic regions (Volles and Lansbury 2007; Soper et al. 2008) . The accumulated vesicular structures contain membraneassociated α-synuclein and sequester the yeast Rab GTPase proteins Ypt1 and Sec4 (Gitler et al. 2008; Soper et al. 2008 ). Because of the suspected role of α-synuclein in regulation of the synaptic vesicle cycle, and the known involvement of Rab GTPases as regulators of vesicle tethering and fusion, we further characterized this vesicle aggregation phenotype. We now demonstrate that functional ablation of the Rab GTPase Ypt6, as well as of other endosomal Rab GTPases, cause a significant increase in vesicle aggregation and toxicity. Furthermore, we demonstrate that yeast cells expressing α-synuclein are sensitive to disruption of endosome-Golgi retrograde trafficking pathways and that this sensitivity is correlated with enhanced vesicle accumulation and toxicity. Finally, we demonstrate α-synuclein associates with phosphatidic acidrich membranes in yeast, and yeast mutants that accumulate acidic phospholipids show a more severe vesicle clustering phenotype. Taken together, these findings are consistent with the idea that α-synuclein associates with Golgiendosomal membranes in a phosphatidic acid-sensitive manner and that excessive membrane binding by α-synuclein interferes with specific vesicle trafficking pathways with resulting cell toxicity.
Materials and Methods

Yeast Strains and Media
The strains CTY182 (MATa, , CTY1-1A (MATa, ura3-52, Δhis3-200, lys2-801am, sec14-1 ts ), CTY159 (MATa, ura3-52, Δhis3-200, lys2-801am, sec14-1 ts , kes1-1), and CTY160 (MATa, ura3-52, Δhis3-200, lys2-801am, sec14-1 ts , cki1-1) were used for phospholipid studies. The BY4741 (MATa, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0) and its associated deletion mutants (Brachmann et al. 1998) were used for all other experiments in this study. Transformation of yeast was performed using a standard lithium polyethylene glycol transformation procedure (Gietz et al. 1997) . Yeast cultures were grown in selective minimal media, containing 2% glucose or 2% galactose, deficient in the required amino acids. For induction of gene expression, cells were cultured in glucose media overnight, and cells from this culture were taken to inoculate a second culture (starting A 600 =0.1) in galactose media, which was then grown at 30°C for 16 h.
Plasmids and Constructs
Integrative α-synuclein-EGFP constructs were generated as previously described (Soper et al. 2008) . Briefly, integrative strains were generated by PCR amplification of the Gal1 promoter, α-syn-EGFP protein sequence, transcription terminator, and selection marker sequence out of the PYES2 vector. Primer sequences were chosen for directed integration into the yeast genome 500 bp upstream of the Gal1 promoter. N-terminal RFP-tagging vectors were generated by PCR cloning of the mcherry RFP (Shaner et al. 2004) sequence with ablation of the stop codon into the pRS 415 vector (ATCC) with either the Ypt1, alcohol dehydrogenase (ADH), or glyceraldehydes-3-phosphate dehydrogenase promoter sequences. Yeast Rab GTPases were PCR cloned and inserted in frame downstream of the RFP sequence. All vectors were sequenced and confirmed before use. The P423 TEF RFP-Spo20 51−91 vector (Nakanishi et al. 2004 ) was kindly donated by Dr. Aaron Neiman (Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794, USA).
Phosphatidic Acid Quantification
Yeast cell cultures were incubated under the appropriate conditions in selective minimal media, pelleted, washed twice with ice-cold water, and the pellets containing 5×10 6 cells flash frozen in liquid nitrogen. Phospholipids were extracted from the cell pellets, prepared for analysis, and phosphatidic acid quantified by mass spectrometry as described (Ivanova et al. 2007 ). Data were normalized against an internal phosphatidic acid standard marked by its odd number acyl-chain carbon property (Ivanova et al. 2007 ).
Growth Assay
Growth was measured on solid media by making serial five-fold dilutions of log-phase cultures, starting with A 600 =1.0. Samples of each dilution were spotted onto minimal media glucose and galactose plates, with appropriate amino acids for selection. Plates were incubated at 30°C for 2-4 days.
Immunoblot Analysis
Cell extracts were prepared as described previously (Kushnirov 2000) . Briefly, cells were grown in galactose media to log-phase. Equal amounts of cells were pelleted by centrifugation, resuspended in one volume water and treated with one volume 0.2 M NaOH for 10 min. Cells were pelleted again, resuspended in SDS/PAGE buffer, and boiled for 5 min and protein samples were separated by SDS/PAGE. For immunoblotting, we used LB509, an anti-α-syn mouse mAb recognizing residues 115-122 (Jakes et al. 1999 ), SNL-1, an affinity-purified rabbit polyclonal α-synuclein antibody raised to amino acid residues 104-119 of α-syn (Giasson et al. 2000) , monoclonal and polyclonal DsRed antibodies (Clontech), and 6C5, a monoclonal GAPDH antibody (Advanced ImmunoChemical Inc.).
Fluorescence Microscopy and Quantification
Cells were grown in galactose minimal media for 16 h and fixed in 4% paraformaldehyde in 40 mM phosphate buffer for 1 h at 30°C. Cells were then washed twice in 40 mM phosphate buffer and mounted on PDL coated dishes for microscopy. Images were captured on a Nikon TE-2000-E (Nikon, Japan) inverted epifluorescence microscope. Typically, the exposure time was between 100 and 2,000 ms, with the camera (CoolSnap-HQ, Photometrics, Tucson, AZ) operating at maximum gain. Images were typically captured at ×60 or ×100 magnification. All image acquisition and processing was done using Metamorph (Molecular Devices, Downingtown, PA). All images were scaled linearly in Metamorph and subsequently mounted in Adobe photoshop (Adobe, San Jose, CA) for display.
Quantification of accumulations was done by capturing images of cultures that had been grown in galactose media for 16 h. Twenty representative fields from four separate cultures were counted, with approximately 250 cells in each field, and cells were scored for presence of accumulations.
Protein Extraction, Immunoprecipitation, and Metabolic Labeling Yeast cultures were grown in galactose media to log phase. Samples were washed once in 20 mM Hepes, pH 7.5, 20 mM NaF, 20 mM NaN 3 , and resuspended in RSB100 buffer (20 mM Tris, 2.5 mM MgCl 2 , 100 mM NaCl, 0.1 mM PMSF, pH 7.4, with protease inhibitors). Cells were lysed by vortexing for 10 min with acid-washed glass beads. Samples were centrifuged at 1,200×g for 4 min; the supernatant was centrifuged again at 1,200×g for 4 min, and then used for immunoprecipitation (IP).
For IP, 50 μL protein A/G beads were incubated with 10 μg of Syn211, an anti-α-synuclein mAb (Giasson et al. 2000) , or T14, an anti-tau mAb, for 1 h at 4°C in 500 μL RSB100 buffer. Beads were washed twice in RSB100 buffer, 20 μg yeast cell extract was added to each IP reaction, and the IP sample was incubated for 1 h at 4°C. Beads were then washed five times, keeping the initial flow through, and resuspended in 50 μL SDS sample buffer for SDS-PAGE.
For metabolic labeling, yeast cultures were grown to log phase in galactose media, washed once with and resuspended in galactose media devoid of Uracil (Ura) and Methionine (Met); 0.5 mCi of [
35 S]-Met was added, and cultures were grown an additional 2 h at 30°C. Samples were then centrifuged and washed once in galactose media without Ura and Met, then washed in RSB100. Protein extraction and immunoprecipitation were then performed as described above, except 200 μg cell extract was used in each IP. SDS-PAGE was performed on a 5-20% tris-glycine gradient gel, fixed in 40% methanol, 10% acetic acid for 20 min. The gel was dried and exposed to a phosphoimager plate for 1 week.
Statistical Analyses
Comparison of sample means and calculation of P values were performed using GraphPad Prism 4.0 software.
Results
Expression of α-Synuclein Disrupts Localization of Rab GTPase Proteins in S. cerevisiae
Previous studies identified two Rab GTPase proteins, Sec4p and Ypt1p, that colocalize with α-synuclein in vesicle aggregates (Soper et al. 2008) . To further evaluate if other Rab GTPases are also involved in α-synuclein-mediated vesicle aggregation, RFP-tagged Rab GTPase proteins were expressed under control of the constitutive ADH promoter in yeast coexpressing Syn-EGFP. The ADH promoter drove physiological levels of Ypt1p expression and the Ypt1 localized properly to endoplasmic reticulum (ER)-to-Golgi vesicles ( Figure S1) .
Surprisingly, all nine of the yeast Rab GTPase proteins that we examined colocalized with Syn-EGFP-labeled vesicle aggregates. This was judged to be a specific effect as RFP alone (Fig. 1a) and RFP-Vma4p (Fig. 1b) , a subunit of the membrane domain of the vacuolar ATPase (Foury 1990) , retained cytoplasmic and vacuole membrane labeling, respectively, in cells expressing EGFP or Syn-EGFP. As expected, RFP-Sec4p (Fig. 1c) localized to punctate secretory structures at the bud neck in EGFP cells (Guo et al. 1999 ) and colocalized with Syn-EGFP-positive puncta in Syn-EGFP cells, verifying that the RFP fusion protein behaves similarly to the HA-tagged protein. However, despite the mislocalization to vesicle aggregates, some RFP-Sec4p is still localized to the bud neck of Syn-EGFP expressing cells suggesting that it is localized correctly (Fig. 1c, arrow) . Similar to previous reports, RFP-Ypt1p localized to punctate Golgi structures in EGFP cells, and colocalized with Syn-EGFP accumulations (Fig. 1d) . We also observed colocalization between α-synuclein and RabGTPases involved in retrograde endosome-Golgi transport (Ypt6p, Fig. 1e ) (Luo and Gallwitz 2003) , endosomevacuole transport and vacuolar inheritance (Ypt7p, Fig. 1f ) (Wichmann et al. 1992; Schimmoller and Riezman 1993) , the endocytic pathway (Ypt10p, Ypt51p, Ypt53p; Fig. 1g , j, k) (Singerkruger et al. 1994; Frei et al. 2006) , and Golgi and post-Golgi trafficking (Ypt31p, Ypt32p; Fig. 1h , i) (Benli et al. 1996) . Localization of RFP-Ypt10p to the vacuole membrane was still observed despite Ypt10p mislocalization, indicating that it may still be capable of performing its normal function in Syn-EGFP expressing cells (Fig. 1g , arrow). The proper localization of Ypt10p, as well as Vma4p, indicates that despite the mislocalization of many RabGTPase proteins onto large aggregates of cytoplasmic vesicles, protein trafficking to the vacuolar membrane was not obviously perturbed.
Yeast Rab GTPases may be targeted to vesicle aggregates by direct interactions between α-synuclein and Rab GTPase proteins. To examine if there is a direct interaction between Rab GTPases and α-synuclein in yeast, we performed co-immunoprecipitation experiments with α-synuclein-EGFP and RFP-labeled Rab GTPases. Using Syn211, a C-terminal α-synuclein mAb, to immunoprecipitate α-synuclein-EGFP from yeast extracts, we were unable to detect a direct interaction between α-synuclein and RFP-Ypt6, RFP-Sec4 ( Figure  S2A ), RFP-Ypt7, or RFP-Ypt31 (data not shown). Moreover, we were unable to identify unique proteins that specifically co-immunoprecipitate with α-synuclein from [ 35 S]-Met radiolabeled yeast cells ( Figure S2B ). These data suggest that α-synuclein induces accumulation and mislocalization of many Rab GTPase proteins in yeast without a requirement for stable, direct physical interactions. Rather, α-synuclein may exert this effect by interfering with vesicular trafficking events.
Ypt6p Defects Enhance α-Synuclein-Induced Vesicle Aggregation
The mislocalization of Rab GTPases to vesicle aggregates may reflect either deranged cycling of Rabs on/off of vesicle membranes or may report a Rab requirement for clustering of these vesicles. To distinguish between these two possibilities, we examined vesicle aggregation in yeast mutants genetically ablated for particular Rab GTPase activities or for the activities of selected components of the vesicle trafficking machinery. Yeast knockout strains expressing Syn-EGFP were induced for 20 h, and the fraction of cells containing vesicle aggregations was quantified (Fig. 2a) . Functional ablation of Ypt6p evoked a four-fold increase in the proportion of Syn-EGFPexpressing cells containing vesicle aggregations (19.22± 1.43% in control vs. 75.05±1.65% in ypt6Δ), while Ypt7p or Ypt51p inactivation supported a mild increase in vesicle aggregation (33.81±2.189% in ypt7Δ, 42.98±2.932% in ypt51Δ). Similarly, inactivation of Gyp8p, a Rab GTPase activating protein, resulted in a mild increase in vesicle aggregations. This effect may reflect its potent ability to accelerate Ypt6p GTP hydrolysis, although Ypt1p, Sec4p Ypt31p, and Ypt32p are also substrates for Gyp8p (De Antoni et al. 2002) . Inactivation of the Ypt10p, Ypt31p, Ypt32p, Ypt52p, or Ypt53p RabGTPases had no effect on Syn-EGFP-induced vesicle aggregation. Similarly, deficiencies in Cdc50p (an endosomal protein involved in polarized growth; Misu et al. 2003) , Rcy1p (a protein involved in plasma membrane protein recycling and early endocytosis; Wiederkehr et al. 2000) , or Snc1p, a v-SNARE involved in secretory vesicle fusion with the plasma membrane; Protopopov et al. 1993) , had no effect on vesicle aggregation in Syn-EGFP-expressing cells (Fig. 2a) .
Western blot analyses (Fig. 2b) indicated that the increase in vesicle aggregation in ypt6Δ mutants was not the trivial consequence of increased α-synuclein-EGFP expression. Rather, the increased vesicle aggregation may be the indirect consequence of increased vesicle content in the cytoplasm of these deletion mutants. Consistent with this possibility, yeast deficient in Ypt6p (Tsukada and Gallwitz 1996) and Ypt51p (Singerkruger et al. 1994 ) do exhibit increased numbers of cytoplasmic vesicles. However, Snc1p defects also result in an increased load of cytoplasmic vesicles (Grote et al. 2000) ; yet, no effect on α-synuclein-induced vesicle aggregation was observed in Snc1p-deficient yeast. We were unable to assess the effect of Sec4p and Ypt1p, as these proteins perform essential housekeeping functions and knockout of these genes are lethal. However, it is unlikely that the secretory vesicle fusion step plays a vital role in vesicle aggregation, as snc1Δ yeast did not show a significant increase in vesicle aggregation. Figure S3 presents a schematic of Rab GTPases that we identified to be involved in α-synucleininduced vesicle aggregation.
To further confirm the role Ypt6 played in α-synucleininduced vesicle aggregation, we asked if RFP-Ypt6p expression in ypt6Δ cells could rescue the enhanced vesicle aggregation phenotype (Fig. 2c, d ). As expected, ectopic RFP-Ypt6p expression-reduced vesicle aggregation down to the level exhibited by control cells (13.50±1.25% in control Syn-EGFP+RFP, 60.59±2.29% in ypt6Δ Syn-EGFP+RFP, 15.07±0.86% in ypt6Δ Syn-EGFP+RFP-Ypt6p). Expression of the negative controls, RFP and RFP-Vma4p, failed to exert rescue. Moreover, Ypt6p-deficient cells are exquisitely sensitive to Syn-EGFP expression, and this sensitivity was also remedied by RFP-Ypt6p production (Fig. 2e) . To examine if Ypt6p expression in otherwise wild-type yeast expressing Syn-EGFP reduces vesicle aggregation, yeast cells were cultured in 5% DMSO to elevate basal levels of vesicle aggregation. Under these conditions, expression of RFP-Ypt6p, but not RFP alone, lowered the fraction of cells exhibiting vesicle aggregations from 41.04± 1.12% to 21.74±1.15% (Fig. 2f) . This effect was not due to reduced Syn-EGFP expression levels (Fig. 2g) .
Taken together, these data implicate Ypt6p as a significant regulator of α-synuclein-induced formation of vesicle aggregations. Not only does Ypt6 dysfunction enhance vesicle aggregation and sensitize cells to Syn-EGFP but also ectopic expression of Ypt6p protects cells against α-synuclein-induced vesicle accumulation.
Disruption of Endosome-Golgi Retrograde Transport
Increases Formation of α-Synuclein-Induced Vesicle Aggregations and Toxicity Ypt6p exchanges bound GDP for GTP in a reaction catalyzed by a heterodimer of two proteins, Ric1p and Rgp1p (Siniossoglou et al. 2000) . As shown in Fig. 3a and d , enhanced Syn-EGFP-dependent vesicle aggregation was observed in both ric1Δ and rgp1Δ mutants (9.04±0.48% in control vs 55.71±1.60% in ric1Δ and 52.25±2.56% in rgp1Δ). Functional ablation of Gyp6p, a GTPase activating protein (GAP) for Ypt6p (Strom et al. 1993) , exerted a modest diminution in the efficiency of Syn-EGFP-induced vesicle aggregation. The weakness of the effect may reflect the involvement of other GAPs in promoting GTP hydrolysis by Ypt6p (Albert and Gallwitz 1999; Vollmer et al. 1999; De Antoni et al. 2002) .
Ypt6p regulates fusion of endocytic vesicles with late Golgi compartments through its functional interaction with the Golgi-associated retrograde protein (GARP) complex. The GARP complex is composed of the Vps51p, Vps52p, Vps53p, and Vps54p subunits (Siniossoglou and Pelham 2001) , and dual inactivation of Vps51p and Ypt6p is incompatible with cell viability (Tong et al. 2004 ). We therefore examined vesicle aggregation in GARP-deficient cells producing Syn-EGFP. Indeed, large increases in formation of vesicle aggregates were scored in the GARP mutants (40.18±2.98% for vps51Δ, 49.62±1.70% for vps52Δ, vps53Δ data not shown, and 41.5 6±1.29% for vps54Δ; Fig. 3a) . The enhanced vesicle aggregation phenotypes were accompanied by enhanced sensitivity of these mutants to Syn-EGFP expression (Fig. 3b) . Again, we did not observe an increase in Syn-EGFP expression level (Fig. 3c) . Several other known Ypt6p interactors were examined, including Imh1p, a Golgi-associated coiled-coil protein containing a GRIP Golgi localization domain that is synthetically lethal with Ypt6p deletions (Munro and Nichols 1999) , andNhx1p, an endosomal Na + /H + exchanger whose dysfunction results in inefficient vesicular trafficking from the prevacuolar compartment (Bowers et al. 2000) and, interestingly, alleviates the temperature sensitive growth deficits of ypt6Δ mutants. Ablation of either Imh1p or Nhx1p did not exert a significant effect on Western blot on extracts used for quantification. Variations in vesicle aggregation are not due to differences in Syn-EGFP expression level. (d) Schematic depicting Ypt6 cycling and endosome-Golgi fusion. Knockouts of Ypt6p, Ric1p, Rgp1p, Vps51p, Vps52p, Vps53p, Vps54p, and Tlg2p result in a large increase in α-syn-induced vesicle aggregation and toxicity. Ric1p/Rgp1p are guanine nucleotide exchange factors for Ypt6p. Vps51p/Vps52p/Vps53p/Vps54p compose the Golgi associated retrograde protein complex (GARP), and Tlg2p is a t-SNARE involved in endosome-Golgi fusion vesicle aggregation in, or growth of, yeast expressing α-synuclein (Fig. 3a, b) . Functional ablation of Vps35p, a component of the retromer protein complex required for cargo retrieval from endosomes to the Golgi (Nothwehr et al. 2000) , resulted in only a mild increase in vesicle aggregation (9.04±0.48% in control, 22.03±1.62% in vps35Δ) without an increase in cell sensitivity to Syn-EGFP expression (Fig. 3a, b) . These modest effects were recorded even though vps35Δ is synthetically lethal with ypt6Δ (Luo and Gallwitz 2003) , Therefore, some (Ric1p, Rgp1p, Vps51p), but not all (Imh1p, Vps35p), components required for cell viability in the face of Ypt6p dysfunction are also sensitized to α-synuclein expression. Likewise, several deficiencies that are tolerated by Ypt6p-deficient yeast (i.e., Vps52, Vps54) are highly sensitized to the presence of α-synuclein. These data suggest that α-synuclein does not have a direct inhibitory effect on Ypt6p, but instead affects Ypt6p-regulated fusion process. Fusion of endosomes to late Golgi compartments requires an interaction between the Ypt6/GARP protein complex and the essential t-SNARE Tlg1p (Siniossoglou and Pelham 2002) . Tlg2p, a related Golgi t-SNARE, forms a SNARE complex with Tlg1p (Coe et al. 1999) and is also involved in endosome-Golgi fusion (Abeliovich et al. 1999 ). Tlg2p itself is not essential for yeast viability, however. Syn-EGFP expression in tlg2Δ yeast resulted in increased vesicle aggregation (9.04±0.48% in control vs 49.86±3.48% in tlg2Δ, Fig. 3a) . The Tlg2p-deficient mutants were also sensitized to Syn-EGFP expression (Fig. 3b) . Finally, affinity capture mass spectrometry experiments report Ypt6p interacts with Hsp82p (Zhao et al. 2005) , the yeast homolog of mammalian Hsp90. This interaction is irrelevant to the robustness of Syn-EGFPdependent vesicle aggregation, however (Fig. 3a) .
In summary, we have identified several genes involved in the regulation of endosome-Golgi fusion that are sensitized to the presence of α-synuclein and have an inhibitory effect on α-synuclein vesicular aggregation. These genes include Ypt6p and its regulators, Ric1p and Rgp1p; components of the GARP, Vps51p, Vps52p, Vps53p, and Vps54p, and the t-SNARE Tlg2p (Fig. 3d) .
α-Synuclein Interacts with Acidic Phospholipids to Promote Formation of Vesicle Aggregations
Previously, we have reported that the formation of α-synuclein-associated vesicle aggregations nucleates at the plasma membrane and requires the α-synuclein N-terminal region (Soper et al. 2008) . Because this region binds acidic phospholipids (Davidson et al. 1998; Rhoades et al. 2006; Stockl et al. 2008) , we compared the localization profiles of α-synuclein-EGFP and RFP-Spo20 51−91 . The RFP chimera harbors the phosphatidic acid-binding region of the Spo20p t-SNARE (Nakanishi et al. 2004 ). Indeed, α-synuclein-EGFP and RFP-Spo20 51−91 strongly colocalize at the plasma membrane in yeast (Fig. 4a) . By contrast, EGFP is diffusely distributed throughout the cytoplasm (Fig. 4b) . Deletion of the first 57 amino acids of the α-synuclein-EGFP chimera, which removes the first four α-synuclein lipid-binding repeats, also produces a protein which is diffusely distributed throughout the cytoplasm.
β-Synuclein-EGFP, which contains an N terminus which resembles that of α-synuclein, colocalizes with RFPSpo20 51−91 at the plasma membrane but does not support formation of the large cytoplasmic vesicle aggregations seen induced by α-synuclein expression, most likely because β-synuclein lacks the hydrophobic NAC domain. Consistent with this scenario, the Δ71-82-α-synuclein-EGFP (for which the hydrophobic NAC domain is also deleted) exhibits a localization profile similar to that of β-synuclein. These data confirm our previous report that the N terminus of α-synuclein is required for lipid binding in the yeast system. Not surprisingly, this N-terminal region is also required for colocalization with RFP-Spo20 51−91 . Small α-syn-EGFP-enriched domains that form at the plasma membrane colocalize with RFP-Spo20 51−91 , suggesting that α-synuclein binding to phosphatidic acid nucleates the early stages of aggregation. Surprisingly, the larger cytoplasmic vesicle aggregations at later time points are no longer populated with a detectable pool of RFPSpo20 51−91 (Fig. 4a) , suggesting that these vesicle aggregates are either depleted of phosphatidic acid or these become enriched in other phospholipids during maturation.
To further examine the role of phosphatidic acid in the formation of α-synuclein-induced vesicle aggregates, the effects of α-synuclein expression were monitored in several sec14 ts mutants that exhibit increased levels of phosphatidic acid. Sec14p is the major yeast phosphatidylinosito/phosphatidylcholine transfer protein, and it plays an essential role in coordinating lipid metabolism with TGN/endosomal membrane dynamics (Salama et al. 1990; Bankaitis et al. 1990; Cleves et al. 1991; Mousley et al. 2008) . The normally essential Sec14p requirement for cell viability is relieved by inactivation of several genes, including the structural genes for yeast choline kinase (Cleves et al. 1991) , and the oxysterol binding protein Kes1p (Fang et al. 1996) . These cki1 and kes1 mutations require the production of a phospholipase D-dependent phosphatidic acid pool for manifestation of "bypass Sec14" phenotypes (Xie et al. 1998) . If phosphatidic acid plays an early role in α-synuclein accumulation in yeast, α-synuclein aggregation phenotypes should be enhanced in these mutants due to expanded phosphatidic acid pools.
We examined α-synuclein-EGFP aggregation in isogenic sec14 ts , sec14 ts cki1, and sec14 ts kes1 mutants both at the sec14 ts permissive (25°C) and restrictive (37°C) temper-atures. Indeed, α-synuclein-EGFP aggregation was markedly increased in all sec14 ts mutants at both restrictive and permissive temperatures (Fig. 5a ). Quantitative analyses revealed enhanced α-synuclein-EGFP aggregation in sec14 ts at 25°C (Fig. 5b, 10 .3±1.6% in controls; 21.9±0.9% in sec14 ts ), and a further two-fold enhancement at 37°C. The kes1 and cki1 "bypass Sec14" mutations failed to alleviate the aggregation phenotype. Rather, the phenotype was even more robust in the "bypass sec14" mutants at both 25°C (34.9±1.9% in sec14ts kes1 and 28.9±2.0% in sec14ts cki1) and 37°C (40.8±0 1.7% in sec14ts kes1 and 47.9±2.5% in sec14ts cki1). These data suggest that enhanced α-synuclein-EGFP aggregation in sec14 ts mutants is not a simple consequence of vesicle trafficking defects as the "bypass Sec14" mutations rescue trafficking defects without alleviating the aggregation phenotypes. Lipidomic analyses confirmed previous demonstrations that sec14 ts and sec14 ts cki1 yeast exhibit elevated bulk cellular phosphatidic acid levels (Xie et al. 1998) and that phosphatidic acid levels were proportionally increased to the robustness of α-synuclein aggregation in these mutants at 25°C and 37°C (Fig. 5c ). These data suggest that α-synuclein interacts with phosphatidic acid rich membranes and that this interaction plays a pivotal role in the disruption of intracellular vesicle trafficking and development of α-synuclein vesicular aggregations.
Discussion
In this study, we have further characterized the formation of α-synuclein-induced vesicle aggregations in S. cerevisiae. Here, we have shown that nine of the eleven yeast Rab GTPases colocalize with these vesicle aggregations, which is surprising considering their known normal localization to many distinct vesicular structures. These data are supported by similar findings in a recent study where multiple Rab GTPases were found to colocalize with α-synuclein in yeast (Gitler et al. 2008) . Colocalization of these Rab GTPase proteins with α-syn in vesicle aggregations suggests that they may be sequestering the Rab GTPases away from their normal target membranes, which could result in wide-spread deficiencies in inter-organelle trafficking. The mechanism by which α-synuclein sequesters Rab GTPases to vesicle aggregations is currently unknown. We were unable to identify a direct physical interaction between α-synuclein and Rab GTPases, although an interaction between A30P α-synuclein and Rab3a, Rab5, . β-Synuclein-EGFP and Δ71-82-α-syn-EGFP colocalize with RFP-Spo20 51−91 at the plasma membrane, but do not form large cytoplasmic accumulations. Scale Bar, (a) 1 μM and Rab8 has been observed in transgenic mice (Dalfo et al. 2004) . Given that Rab GTPases cycle on and off membranes (Soldati et al. 1993) , their colocalization with vesicle aggregations may simply be a result of mistargeting to these vesicles and not a direct interaction with α-synuclein.
We found that deletion of three Rab GTPases, Ypt6p, Ypt7p, and Ypt51p, resulted in an increase in vesicle aggregations. All three of these Rab GTPases are involved with the endocytic pathway (Wichmann et al. 1992; Singerkruger et al. 1994; Luo and Gallwitz 2003) , suggesting that the vesicles found in these accumulations originate from the endocytotic pathway. Deletion of Ypt6 in particular resulted in a dramatic increase in vesicle aggregations and toxicity, which was able to be rescued by expression of RFPYpt6p, but not RFP alone or RFP-Vma4. Furthermore, we demonstrated the ability of overexpressed Ypt6p to reduce vesicle aggregation in wild type yeast cells.
To further examine this phenomenon, we expressed α-synuclein in yeast with deletions of known Ypt6 effector proteins. Deletion of either Ric1p or Rgp1p, GTP exchange factors for Ypt6p, results in an increase in vesicle aggregation and toxicity, similar to the effect seen in Ypt6Δ cells. Therefore, functional Ypt6p inhibits the formation or promotes the removal of α-synucleininduced vesicle aggregations. Ypt6p regulates retrograde endosome-Golgi fusion through an interaction with the GARP complex, composed of Vps51p, Vps52p, Vps53p, and Vps54p (Siniossoglou and Pelham 2002) . Deletion of any of these GARP components results in an increase in vesicle aggregation and toxicity. Interestingly, although Vps51p is the only GARP component reported to be synthetically lethal with Ypt6p; Vps51p, Vps52p, and Vps54p caused synthetic lethality with α-synuclein. These data imply that α-synuclein is not directly inhibiting Ypt6p, as α-synuclein causes synthetic lethality with different genes than does Ypt6p knockout strain. Our findings suggest that α-synuclein interferes with an endosomeGolgi trafficking event that is downstream from, but dependent on, Ypt6p-mediated tethering of endosomes to the Golgi.
Fusion of endosomes with the Golgi requires association of the GARP complex with an essential Golgi t-SNARE, Fig. 5 Sec14ts and sec14ts bypass mutants increase α-synuclein accumulation in S. cerevisiae. (a) Fluorescence images of control, sec14ts, sec14ts kes1, and sec14ts cki1 cells expressing α-synuclein-EGFP at 25°C and 37°C. (b) Quantification of accumulation formation in control, sec14ts, sec14ts kes1, and sec14ts cki1 cells. Accumulation did not increase in control cells when shifted from 25°C to 37°C. Accumulation levels significantly increased in sec14ts, sec14ts kes1, and sec14ts cki1 strains when shifted from 25°C to 37°C. Sec14ts kes1 and sec14ts cki1 had higher baseline levels of accumulation than sec14ts and control cells. (c) Mass spec analysis of phosphatidic acid (PA) in pooled samples of control, sec14ts, and sec14ts cki1 cells. Sec14ts and sec14ts cki cells had higher levels of PA at 25°C. Shifting cells to 37°C increased PA levels in all strains. Scale Bar, (a) 2 μM Tlg1p (Siniossoglou and Pelham 2001; Siniossoglou and Pelham 2002) and another non-essential t-SNARE, Tlg2p (Abeliovich et al. 1999) . Deletion of Tlg2p is not toxic to yeast cells; however, it causes toxicity and massive vesicle aggregation in yeast expressing α-synuclein. These data suggest that α-synuclein directly interferes with endosomeGolgi trafficking. α-Synuclein may play a role in the formation of SNARE complexes, as has been observed in mouse models (Chandra et al. 2005) , or antagonize SNARE function, as has been observed in mammalian cells (Thayanidhi et al. 2010) .
We hypothesize that one function of α-synuclein is to regulate vesicular fusion, through an unknown mechanism. Overexpression of α-synuclein may stall vesicular fusion, and in yeast this specifically causes massive accumulation of vesicles and toxicity associated with disruption of endosomeGolgi trafficking. These data are consistent with observations of increased synaptic vesicle pools in PC12 cells overexpression α-synuclein (Larsen et al. 2006) , and the observation that α-synuclein knockout mice have a reduction in both docked and reserve synaptic vesicle pools in hippocampal neurons (Chandra et al. 2004 ). α-Synuclein has also been shown to interfere with exocytosis and synaptic vesicle recycling in mammalian neurons (Scott et al. 2010; Nemani et al. 2010) , which may be the result of a similar toxic mechanism.
While we observed a specific defect in endosome-Golgi retrograde trafficking in yeast expressing α-synuclein, we have not ruled out that α-synuclein may cause defects in vesicle fusion at multiple transport steps. Indeed, it has been reported that expression of α-synuclein causes deficits in endocytosis in yeast , deficits in ER-Golgi trafficking (Cooper et al. 2006) and that yeast expressing α-synuclein are sensitive to disruption of vesicular trafficking (Willingham et al. 2003; Zabrocki et al. 2008) . These data are further supported by the recent observation that disruption of endocytosis in α-synuclein expressing worms results in severe growth impairments and motor dysfunction (Kuwahara et al. 2008) . These observations support disruption of endocytosis as a possible mechanism for α-synuclein toxicity.
Cooper et al. have reported that α-synuclein induces carboxypeptidase Y (CPY) and alkaline phosphatase (ALP) glycosylation defects and that these defects and toxicity can be rescued by overexpression of the Rab GTPase, Ypt1p. These observations are consistent with reported phenotypes in yeast harboring a temperature-sensitive Ypt6p mutation. It has been shown that temperature-sensitive Ypt6p mutants have deficits in CPY and ALP trafficking, possibly through an inhibition of retrograde transport of glycotransferases and that these cells can be rescued by overexpression of Ypt1p (Luo and Gallwitz 2003) . A specific sensitivity to disruption of Ypt1p through overexpression of a dominantnegative form of the protein in the presence of α-synuclein has been previously reported, indicating that α-synuclein may affect ER-Golgi trafficking (Cooper et al. 2006 ). Gitler et al. have reported α-synuclein-induced deficit in vesicle fusion in a cell-free ER-Golgi transport assay (Gitler et al. 2008) , whereas in this study, we have demonstrated that α-synuclein may interfere with a fusion event at the endosome-Golgi step. Given α-synuclein's synaptic localization in mammals, it is reasonable to assume that α-synuclein can regulate vesicle fusion at the synapse. The surprising trafficking phenotypes observed in yeast may be due to the conservation of basic SNAREmediated vesicle fusion machinery between yeast and mammals (Kloepper et al. 2007) .
In this study, we have further examined the relationship between α-synuclein membrane localization and accumulation. Significantly, we have found that α-synuclein colocalizes with the phosphatidic acid marker Spo20 51−91 at the plasma membrane and in early accumulations. Yeast strains that produce increased pools of phosphatidic acid show increased accumulations. These data may also explain the strong membrane localization and vesicle aggregation phenotype in yeast, as yeast plasma membrane is particularly enriched for acidic phospholipids compared to other organelle membranes (Zinser and Daum 1995) . These observations suggest that the known membrane binding properties of α-synuclein may be important in the early stages of its toxic function in yeast, and that disruption of α-synuclein phospholipid binding may be a possible therapeutic mechanism for the treatment of Parkinson's disease It is provocative to speculate on the relationship between α-synuclein-induced vesicle aggregation and neurodegeneration in PD. α-Synuclein fibrillization has long been studied as a potential pathogenic mechanism, and vesicle content has been observed in Lewy bodies and pale bodies in PD (Duffy and Tennyson 1965; Forno and Norville 1976; Watanabe et al. 1977; Hayashida et al. 1993; Soper et al. 2008) . It is possible that accumulation of vesicles may serve as a "seed" to induce formation of α-synuclein fibrils and subsequent inclusion formation, due to the high concentration of α-synuclein in these accumulations. Alternatively, disruption of trafficking events by α-synuclein could directly cause toxicity in neurons, particularly in the affected dopaminergic neurons in PD patients. Accumulation of dopamine-containing vesicles may result in accumulation of potentially toxic dopamine metabolites, resulting in selective degeneration of dopaminergic neurons . Further characterization of the role α-synuclein plays in vesicle tethering and fusion, as well as the functional consequences of α-synuclein interaction with acidic phospholipids, may provide important insights into both the normal function and abnormal pathogenic function of α-synuclein and could reveal new therapeutic targets for the treatment of Parkinson's disease.
